Ethical Committee Approval
Ethical Committee Approval
To
Clinical Geneticist,
TamilNadu, India
Subject: Approval of the clinical study – “A Prospective Study on Congenital Anomalies and their Genetic
Predisposition” by the Institutional Ethical Committee
The Benchmark Medical Trust, Institutional Ethical Committee (BMT, IEC) has reviewed and discussed
your application to conduct the above mentioned clinical research study, with yourself as the Principal
The following list of all documents submitted to IEC that have been verified, reviewed and approved:
The following members of the Ethical committee were present at the virtual meeting held on 27.07.2022
Affiliation to
S.No Name Designation Qualification Gender Attendance
Institute
Dr. Ganeshkumar
1 Chairman MS (Ophthal) Male Yes No
Jayakrishnan
Dr. Ramasamy MBBS,
2 Secretary Male No Yes
Valliappan PGDH.SC
Joint MD, DM
3 Dr. S. Krupashankar Male Yes No
Secretary (Med. Onco)
Social
4 Mr. S. Nandagopal B. Tech Male Yes No
Scientist
5 Mr. C.R. Jaimurugan Legal advisor B.A, B.L Male Yes Yes
6 Dr. R. Preethi Member MDRD Female No Yes
7 Mr. R. Kannan Lay person Male Yes No
None of the Principal Investigator and co-investigators participating in this study took part in the decision
making and voting procedure of the approval process for this study.
This Ethical committee is working in accordance to ICH-GCP principles, Schedule Y and ICMR guidelines and
other applicable statutory regulations.
The Institutional Ethical Committee expects to be informed about the progress of the study and provided with
a copy of the final report.
The Principal Investigator is expected to notify the IEC of any modification/revision of the approved study
protocol, patient data, informed consent and of any serious adverse events (SAE) occurring during the course
of the study, within a week. The committee reserves the right to revoke/terminate approval status if needed.
Yours Sincerely,